 | NIO | Name: | NICOTINIC ACID | Formula: | C6 H5 N O2 | SMILES: | O=C(O)c1cccnc1 | InChi: | InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9) | Definition date: | 1999-07-08 | Last modified: | 2024-10-02 | Identifier: | pyridine-3-carboxylic acid |
|
 | W3T | Name: | 1-[(1~{S},5~{R})-3-[7-(8-ethynyl-7-fluoranyl-3-oxidanyl-naphthalen-1-yl)-8-fluoranyl-2-[[(2~{R},8~{S})-2-fluoranyl-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]ethanone | Formula: | C35 H33 F3 N6 O3 | SMILES: | CC(=O)N1[CH]2CC[CH]1CN(C2)c3nc(OC[C]45CCCN4C[CH](F)C5)nc6c(F)c(ncc36)c7cc(O)cc8ccc(F)c(C#C)c78 | InChi: | InChI=1S/C35H33F3N6O3/c1-3-25-28(37)8-5-20-11-24(46)12-26(29(20)25)31-30(38)32-27(14-39-31)33(42-16-22-6-7-23(17-42)44(22)19(2)45)41-34(40-32)47-18-35-9-4-10-43(35)15-21(36)13-35/h1,5,8,11-12,14,21-23,46H,4,6-7,9-10,13,15-18H2,2H3/t21-,22-,23+,35+/m1/s1 | Definition date: | 2023-09-19 | Last modified: | 2024-10-02 | Release date: | 2024-09-11 | Identifier: | 1-[(1~{S},5~{R})-3-[7-(8-ethynyl-7-fluoranyl-3-oxidanyl-naphthalen-1-yl)-8-fluoranyl-2-[[(2~{R},8~{S})-2-fluoranyl-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]ethanone |
|
 | K5L | Name: | (2~{R})-2-azanyl-3-(3-oxidanyl-3-oxidanylidene-propanoyl)oxy-propanoic acid | Formula: | C6 H9 N O6 | SMILES: | N[CH](COC(=O)CC(O)=O)C(O)=O | InChi: | InChI=1S/C6H9NO6/c7-3(6(11)12)2-13-5(10)1-4(8)9/h3H,1-2,7H2,(H,8,9)(H,11,12)/t3-/m1/s1 | Definition date: | 2017-01-25 | Last modified: | 2024-10-02 | Release date: | 2018-01-24 | Identifier: | (2~{R})-2-azanyl-3-(3-oxidanyl-3-oxidanylidene-propanoyl)oxy-propanoic acid |
|
 | A1L0C | Name: | [(1R)-1-[(1-cyclohexyl-1,2,3-triazol-4-yl)carbonylamino]-3-methyl-butyl]boronic acid | Formula: | C14 H25 B N4 O3 | SMILES: | CC(C)C[CH](NC(=O)c1cn(nn1)C2CCCCC2)B(O)O | InChi: | InChI=1S/C14H25BN4O3/c1-10(2)8-13(15(21)22)16-14(20)12-9-19(18-17-12)11-6-4-3-5-7-11/h9-11,13,21-22H,3-8H2,1-2H3,(H,16,20)/t13-/m0/s1 | Definition date: | 2024-04-09 | Last modified: | 2024-10-02 | Release date: | 2024-07-31 | Identifier: | [(1~{R})-1-[(1-cyclohexyl-1,2,3-triazol-4-yl)carbonylamino]-3-methyl-butyl]boronic acid |
|
 | A1L0D | Name: | [(~{R})-cyclohexyl-[(1-cyclohexyl-1,2,3-triazol-4-yl)carbonylamino]methyl]boronic acid | Formula: | C16 H27 B N4 O3 | SMILES: | OB(O)[CH](NC(=O)c1cn(nn1)C2CCCCC2)C3CCCCC3 | InChi: | InChI=1S/C16H27BN4O3/c22-16(18-15(17(23)24)12-7-3-1-4-8-12)14-11-21(20-19-14)13-9-5-2-6-10-13/h11-13,15,23-24H,1-10H2,(H,18,22)/t15-/m0/s1 | Definition date: | 2024-04-09 | Last modified: | 2024-10-02 | Release date: | 2024-07-31 | Identifier: | [(~{R})-cyclohexyl-[(1-cyclohexyl-1,2,3-triazol-4-yl)carbonylamino]methyl]boronic acid |
|
 | I77 | Name: | 5'-(hydrazinecarbonyl)[2,2'-bipyridine]-5-carboxamide | Formula: | C12 H11 N5 O2 | SMILES: | NC(=O)c1cnc(cc1)c1ccc(cn1)C(=O)NN | InChi: | InChI=1S/C12H11N5O2/c13-11(18)7-1-3-9(15-5-7)10-4-2-8(6-16-10)12(19)17-14/h1-6H,14H2,(H2,13,18)(H,17,19) | Definition date: | 2022-01-20 | Last modified: | 2024-10-02 | Release date: | 2022-04-20 | Identifier: | 5'-(hydrazinecarbonyl)[2,2'-bipyridine]-5-carboxamide |
|
 | 4AW | Name: | 4-AZATRYPTOPHAN | Formula: | C10 H11 N3 O2 | SMILES: | O=C(O)C(N)Cc2c1ncccc1nc2 | InChi: | InChI=1S/C10H11N3O2/c11-7(10(14)15)4-6-5-13-8-2-1-3-12-9(6)8/h1-3,5,7,13H,4,11H2,(H,14,15)/t7-/m0/s1 | Definition date: | 2012-07-16 | Last modified: | 2024-09-27 | Release date: | 2013-05-29 | Identifier: | 3-(1H-pyrrolo[3,2-b]pyridin-3-yl)-L-alanine |
|
 | XCK | Name: | N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-{[2-methyl-2-(phenylsulfanyl)propoxy]carbonyl}-L-leucinamide | Formula: | C24 H36 N4 O4 S | SMILES: | CC(C)CC(NC(=O)OCC(C)(C)Sc1ccccc1)C(=O)NC(CC1CCNC1=O)C=N | InChi: | InChI=1S/C24H36N4O4S/c1-16(2)12-20(22(30)27-18(14-25)13-17-10-11-26-21(17)29)28-23(31)32-15-24(3,4)33-19-8-6-5-7-9-19/h5-9,14,16-18,20,25H,10-13,15H2,1-4H3,(H,26,29)(H,27,30)(H,28,31)/b25-14-/t17-,18-,20-/m0/s1 | Definition date: | 2022-11-11 | Last modified: | 2024-09-27 | Release date: | 2022-11-23 | Identifier: | N-{(1Z,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-{[2-methyl-2-(phenylsulfanyl)propoxy]carbonyl}-L-leucinamide |
|
 | YV6 | Name: | methyl (3S)-1-[N-(4-sulfanylbutanoyl)-L-valyl-3-hydroxy-L-phenylalanyl]-1,2-diazinane-3-carboxylate | Formula: | C24 H36 N4 O6 S | SMILES: | O=C(N1CCCC(N1)C(=O)OC)C(Cc1cccc(O)c1)NC(=O)C(NC(=O)CCCS)C(C)C | InChi: | InChI=1S/C24H36N4O6S/c1-15(2)21(26-20(30)10-6-12-35)22(31)25-19(14-16-7-4-8-17(29)13-16)23(32)28-11-5-9-18(27-28)24(33)34-3/h4,7-8,13,15,18-19,21,27,29,35H,5-6,9-12,14H2,1-3H3,(H,25,31)(H,26,30)/t18-,19-,21-/m0/s1 | Definition date: | 2023-02-22 | Last modified: | 2024-09-27 | Release date: | 2023-08-16 | Identifier: | methyl (3S)-1-[N-(4-sulfanylbutanoyl)-L-valyl-3-hydroxy-L-phenylalanyl]-1,2-diazinane-3-carboxylate |
|
 | SVA | Name: | SERINE VANADATE | Formula: | C3 H7 N O7 V | SMILES: | [O-][V]([O-])([O-])(O)OCC(N)C(=O)O | InChi: | InChI=1S/C3H6NO3.H2O.3O.V/c4-2(1-5)3(6)7 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | For multi-component charged structures, a total zero charge is required! |
|
 | YV7 | Name: | D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-fluoro-L-phenylalaninamide | Formula: | C29 H37 F N4 O5 | SMILES: | Fc1ccc(cc1)CC(NC(=O)C(N)Cc1ccccc1)C(=O)NC(CC1CCNC1=O)CCC(=O)OCC | InChi: | InChI=1S/C29H37FN4O5/c1-2-39-26(35)13-12-23(18-21-14-15-32-27(21)36)33-29(38)25(17-20-8-10-22(30)11-9-20)34-28(37)24(31)16-19-6-4-3-5-7-19/h3-11,21,23-25H,2,12-18,31H2,1H3,(H,32,36)(H,33,38)(H,34,37)/t21-,23+,24+,25-/m0/s1 | Definition date: | 2021-04-01 | Last modified: | 2024-09-27 | Release date: | 2022-10-12 | Identifier: | D-phenylalanyl-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-fluoro-L-phenylalaninamide |
|
 | UUH | Name: | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[4-[2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaen-8-yl]butyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol | Formula: | C26 H36 B F2 N5 O4 | SMILES: | Cc1cc(C)c2n1[B-](F)(F)[N+]3=C(C)C=C(C)C3=C2CCCCc4cn(C[CH]5[CH](O)C[CH](O)[CH](O)[CH]5O)nn4 | InChi: | InChI=1S/C26H36BF2N5O4/c1-14-9-16(3)33-23(14)19(24-15(2)10-17(4)34(24)27(33,28)29)8-6-5-7-18-12-32(31-30-18)13-20-21(35)11-22(36)26(38)25(20)37/h9-10,12,20-22,25-26,35-38H,5-8,11,13H2,1-4H3/t20-,21-,22-,25+,26+/m0/s1 | Definition date: | 2021-03-19 | Last modified: | 2024-09-27 | Release date: | 2022-03-30 | Identifier: | (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[4-[2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaen-8-yl]butyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol |
|
 | 4AY | Name: | 4-(bromomethyl)benzoic acid | Formula: | C8 H7 Br O2 | SMILES: | BrCc1ccc(C(=O)O)cc1 | InChi: | InChI=1S/C8H7BrO2/c9-5-6-1-3-7(4-2-6)8(10)11/h1-4H,5H2,(H,10,11) | Definition date: | 2015-02-21 | Last modified: | 2024-09-27 | Release date: | 2016-03-02 | Identifier: | 4-(bromomethyl)benzoic acid |
|
 | Y4J | Name: | (1R,2S)-2-((S)-2-(((((1R,3R,5S)-bicyclo[3.3.1]non-6-en-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | Formula: | C24 H39 N3 O8 S | SMILES: | N(C(=O)C(CC(C)C)NC(OCC1CC2CC(C1)CC=C2)=O)C(CC3C(NCC3)=O)C(O)S(=O)(O)=O | InChi: | InChI=1S/C24H39N3O8S/c1-14(2)8-19(27-24(31)35-13-17-10-15-4-3-5-16(9-15)11-17)22(29)26-20(23(30)36(32,33)34)12-18-6-7-25-21(18)28/h3-4,14-20,23,30H,5-13H2,1-2H3,(H,25,28)(H,26,29)(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19-,20-,23+/m0/s1 | Definition date: | 2021-02-03 | Last modified: | 2024-09-27 | Release date: | 2021-02-17 | Identifier: | (1R,2S)-2-{[N-({[(1R,3R,5S)-bicyclo[3.3.1]non-6-en-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | XCN | Name: | S-cyano-L-cysteine | Formula: | C4 H6 N2 O2 S | SMILES: | O=C(O)C(N)CSC#N | InChi: | InChI=1S/C4H6N2O2S/c5-2-9-1-3(6)4(7)8/h3H,1,6H2,(H,7,8)/t3-/m0/s1 | Definition date: | 2010-09-21 | Last modified: | 2024-09-27 | Identifier: | S-cyano-L-cysteine |
|
 | QGT | Name: | ~{N}-tridecylmethanethioamide | Formula: | C14 H29 N S | SMILES: | CCCCCCCCCCCCCNC=S | InChi: | InChI=1S/C14H29NS/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-14-16/h14H,2-13H2,1H3,(H,15,16) | Synonyms: | Tetradecyl-1-isothiocyanate (reacted form) | Definition date: | 2020-06-16 | Last modified: | 2024-09-27 | Release date: | 2023-07-12 | Identifier: | ~{N}-tridecylmethanethioamide |
|
 | PN7 | Name: | N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-(2-sulfanylethyl)-beta-alaninamide | Formula: | C11 H23 N2 O7 P S | SMILES: | OC(C(C)(COP(O)(O)=O)C)C(=O)NCCC(NCCS)=O | InChi: | InChI=1S/C11H23N2O7PS/c1-11(2,7-20-21(17,18)19)9(15)10(16)13-4-3-8(14)12-5-6-22/h9,15,22H,3-7H2,1-2H3,(H,12,14)(H,13,16)(H2,17,18,19)/t9-/m1/s1 | Definition date: | 2015-07-16 | Last modified: | 2024-09-27 | Release date: | 2016-01-20 | Identifier: | N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-(2-sulfanylethyl)-beta-alaninamide |
|
 | NZV | Name: | ceftriaxone, bound form | Formula: | C18 H20 N8 O8 S3 | SMILES: | O=C(/C(c1csc(N)n1)=NOC)NC(C(O)=O)C2SCC(=C(N2)C(O)=O)CSC=3N(NC(C(N=3)=O)=O)C | InChi: | InChI=1S/C18H20N8O8S3/c1-26-18(23-12(28)13(29)24-26)37-4-6-3-35-14(22-8(6)15(30)31)10(16(32)33)21-11(27)9(25-34-2)7-5-36-17(19)20-7/h5,10,14,22H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,24,29)(H,30,31)(H,32,33)/b25-9-/t10-,14+/m0/s1 | Definition date: | 2019-05-30 | Last modified: | 2024-09-27 | Release date: | 2019-08-07 | Identifier: | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}(carboxy)methyl]-5-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | S1Y | Name: | [(2S,3R)-1-{[(4S)-1-(2-aminoethyl)azepan-4-yl]carbamoyl}-2-formylpyrrolidin-3-yl]sulfamic acid | Formula: | C14 H27 N5 O5 S | SMILES: | O=S(=O)(O)NC2C(C=O)N(C(=O)NC1CCCN(CCN)CC1)CC2 | InChi: | InChI=1S/C14H27N5O5S/c15-5-9-18-6-1-2-11(3-7-18)16-14(21)19-8-4-12(13(19)10-20)17-25(22,23)24/h10-13,17H,1-9,15H2,(H,16,21)(H,22,23,24)/t11-,12+,13+/m0/s1 | Definition date: | 2011-05-17 | Last modified: | 2024-09-27 | Identifier: | [(2S,3R)-1-{[(4S)-1-(2-aminoethyl)azepan-4-yl]carbamoyl}-2-formylpyrrolidin-3-yl]sulfamic acid |
|
 | 192 | Name: | 1-AMINOCYCLOBUTANECARBOXLIC ACID | Formula: | C5 H9 N O2 | SMILES: | O=C(O)C1(N)CCC1 | InChi: | InChI=1S/C5H9NO2/c6-5(4(7)8)2-1-3-5/h1-3,6H2,(H,7,8) | Definition date: | 2004-11-23 | Last modified: | 2024-09-27 | Identifier: | 1-aminocyclobutanecarboxylic acid |
|
 | N6K | Name: | ~{N}-(1~{H}-indazol-5-ylmethyl)ethanesulfonamide | Formula: | C10 H13 N3 O2 S | SMILES: | CC[S](=O)(=O)NCc1ccc2[nH]ncc2c1 | InChi: | InChI=1S/C10H13N3O2S/c1-2-16(14,15)12-6-8-3-4-10-9(5-8)7-11-13-10/h3-5,7,12H,2,6H2,1H3,(H,11,13) | Synonyms: | N-(1H-indazol-5-ylmethyl)ethenesulfonamide (precursor) | Definition date: | 2022-08-12 | Last modified: | 2024-09-27 | Release date: | 2022-09-28 | Identifier: | ~{N}-(1~{H}-indazol-5-ylmethyl)ethanesulfonamide |
|
 | UUK | Name: | tert-butyl (1-((4-(dibenzylamino)-4-oxobutyl)amino)-4-methyl-1-oxopentan-2-yl)carbamate | Formula: | C29 H41 N3 O4 | SMILES: | CC(C)C[CH](NC(=O)OC(C)(C)C)C(=O)NCCCC(=O)N(Cc1ccccc1)Cc2ccccc2 | InChi: | InChI=1S/C29H41N3O4/c1-22(2)19-25(31-28(35)36-29(3,4)5)27(34)30-18-12-17-26(33)32(20-23-13-8-6-9-14-23)21-24-15-10-7-11-16-24/h6-11,13-16,22,25H,12,17-21H2,1-5H3,(H,30,34)(H,31,35)/t25-/m0/s1 | Synonyms: | ~{tert}-butyl ~{N}-[(2~{S})-1-[[4-[bis(phenylmethyl)amino]-4-oxidanylidene-butyl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate | Definition date: | 2021-03-19 | Last modified: | 2024-09-27 | Release date: | 2021-09-08 | Identifier: | ~{tert}-butyl ~{N}-[(2~{S})-1-[[4-[bis(phenylmethyl)amino]-4-oxidanylidene-butyl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate |
|
 | XCP | Name: | (1S,2S)-2-aminocyclopentanecarboxylic acid | Formula: | C6 H11 N O2 | SMILES: | O=C(O)C1CCCC1N | InChi: | InChI=1S/C6H11NO2/c7-5-3-1-2-4(5)6(8)9/h4-5H,1-3,7H2,(H,8,9)/t4-,5-/m0/s1 | Definition date: | 2008-02-05 | Last modified: | 2024-09-27 | Identifier: | (1S,2S)-2-aminocyclopentanecarboxylic acid |
|
 | 193 | Name: | (2S)-4-(BETA-ALANYLAMINO)-2-AMINOBUTANOIC ACID | Formula: | C7 H15 N3 O3 | SMILES: | O=C(O)C(N)CCNC(=O)CCN | InChi: | InChI=1S/C7H15N3O3/c8-3-1-6(11)10-4-2-5(9)7(12)13/h5H,1-4,8-9H2,(H,10,11)(H,12,13)/t5-/m0/s1 | Definition date: | 2004-11-30 | Last modified: | 2024-09-27 | Identifier: | (2S)-4-(beta-alanylamino)-2-aminobutanoic acid |
|
 | NKK | Name: | N~2~-(naphthalen-2-ylcarbonyl)-L-lysyl-N-[(1S)-4-carbamimidamido-1-formylbutyl]-L-lysinamide | Formula: | C29 H44 N8 O4 | SMILES: | O=CC(NC(=O)C(NC(=O)C(NC(=O)c2ccc1c(cccc1)c2)CCCCN)CCCCN)CCCNC(=[N@H])N | InChi: | InChI=1S/C29H44N8O4/c30-15-5-3-11-24(27(40)35-23(19-38)10-7-17-34-29(32)33)37-28(41)25(12-4-6-16-31)36-26(39)22-14-13-20-8-1-2-9-21(20)18-22/h1-2,8-9,13-14,18-19,23-25H,3-7,10-12,15-17,30-31H2,(H,35,40)(H,36,39)(H,37,41)(H4,32,33,34)/t23-,24-,25-/m0/s1 | Definition date: | 2008-08-22 | Last modified: | 2024-09-27 | Identifier: | N~2~-(naphthalen-2-ylcarbonyl)-L-lysyl-N-[(1S)-4-carbamimidamido-1-formylbutyl]-L-lysinamide |
|